ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO051

Renal PET/CT-Rubidium-82 (Rb-82) Is a Precise and Reliable Method for Determination of Renal Blood Flow (RBF)

Session Information

Category: Bioengineering

  • 300 Bioengineering

Authors

  • Langaa, Stine, Holstebro Hospital, Holstebro, Denmark
  • Lauridsen, Thomas Guldager, Holstebro Hospital, Holstebro, Denmark
  • Fynbo, Claire A., Herning Hospital, Herning, Denmark
  • Theil, Jorn, Herning Hospital, Herning, Denmark
  • Bech, Jesper N., Holstebro Hospital, Holstebro, Denmark
Background

Changes in RBF may play a pathophysiological role in hypertension and kidney disease; however, RBF determination in humans has proven difficult.
In a previous study, we demonstrated that RBF estimation based on PET/CT and Rb-82 is feasible and established that RBF can be determined based on a single PET/CT-Rb-82 scan, hereby minimizing radiation exposure associated with the method. We also found an intra-assay coefficient of variation of approximately 5.5% for both kidneys which indicates that the method is precise.
The aim of this study is to test the reliability of renal PET/CT-Rb-82 for RBF estimation.

Methods

Ten healthy subjects underwent three dynamic PET/CT-Rb-82 scans spread over two days. Rb-82 was given as bolus injections. On day 1, a single 8 min dynamic scan was performed. On day 2, an 8 min dynamic scan was performed before and after RBF was stimulated by a two-hour long infusion of an amino acid-solution. Time activity curves of arterial activity and renal uptake were recorded, and a 1-tissue compartment model was used for Rb-82 renal clearance estimation using PMOD® software. The clearance constant K1 in the model represents RBF. The day-to-day variation was calculated as the difference between the unstimulated K1-values on day 1 and day 2. K1-values determined before and after RBF stimulation on day 2 were compared.

Results

The mean unstimulated K1 value was 1.80 ± 0.17 ml/min/g for the right kidney and 1.78 ± 0.19 ml/min/g for the left kidney. The mean stimulated K1 value was 1.97 ± 0.17 ml/min/g for the right kidney and 1.95 ± 0.19 ml/min/g for the left kidney. There was no significant difference between the right and the left kidney for either the unstimulated or the stimulated K1 values. The day-to-day variation was 5.2% for the right kidney and 5.3% for the left kidney. For both kidneys, K1-values determined after RBF stimulation were significantly higher than K1-values determined before stimulation.

Conclusion

The approximate 5% day-to-day variation was acceptably low. For both kidneys, a significant increase in RBF was detected after application of a well-documented RBF stimulus. In conclusion, our preliminary results indicate that renal PET/CT-Rb-82 is a precise and reliable method for RBF determination.

Funding

  • Government Support - Non-U.S.